Japan Vitamin B12 Market Size & Outlook, 2025-2033
Japan Vitamin B12 Market Insights
- Deep Market Insights analysis indicates that the Japan Vitamin B12 Market size, valued at USD 8.17 Million in 2024, is expected to expand to USD 14.31 Million by 2033.
- The Japan market is forecasted to expand at a CAGR of 6.37% spanning 2026–2033.
- Cyanocobalamin held the leading position among Form segments in 2024, based on market size.
- Cyanocobalamin is projected to post the fastest growth rate, sustaining its position as the most attractive Form segment during the forecast horizon.
![Japan Vitamin B12 Market Size, Share & Growth Report By [2033]](https://deepmarketinsights.com/uploads/charts/japan-vitamin-b12-market-japan-form-223617.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Japan contributed 3.91% to the global Vitamin B12 Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Vitamin B12 Market.
- In Asia Pacific, China is projected to capture the leading share of market size by 2033.
- Among Asia Pacific markets, China is expected to post the fastest growth, reaching USD 43.63 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 8.17 Million |
| Market Size In 2033 | USD 14.31 Million |
| Largest segment | Cyanocobalamin |
| Units | Revenue in USD Million |
| CAGR | 6.37% (2025-2033) |
| Segmnetation Covered | |
| Form |
|
| Application |
|
| Route |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Japan Vitamin B12 Market Form 2025-2033 (USD Million)
| Form | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cyanocobalamin | XX.x | XX.x | XX.x | 3.72 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Methylcobalamin | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hydroxocobalamin | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Japan Vitamin B12 Market Application 2025-2033 (USD Million)
| Application | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharma | XX.x | XX.x | XX.x | 4.21 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Fortified food | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Japan Vitamin B12 Market Route 2025-2033 (USD Million)
| Route | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | XX.x | XX.x | XX.x | 4.25 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Injectable | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Sublingual | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.